Medication info
Telmisartan and Amlodipine Tablets 40/10 mg

Telmisartan and Amlodipine Tablets 40/10 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Hubist Pharmaceutical Co., Ltd.
Appearance
Biconvex oval bicolor tablet, white and light blue
Packaging
PTP - 30 tablets/PTP[(10 tablets/PTP x 3)], bottle packaging - 30 tablets/bottle, bottle packaging - 100 tablets/bottle
Approval status
Active

MFDS item code 201700730 · Approved 2017.02.13 · Insurance code 628801000

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not adequately controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring cautious administration’.) In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Child dose
This medicine is not recommended for use in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
Hubist Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not sufficiently controlled with either telmisartan or amlodipine monotherapy. It helps to lower blood pressure more effectively for better management of hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not adequately controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring cautious administration’.) In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.

Child dose

This medicine is not recommended for use in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Precautions

This medication can cause severe problems for the fetus or newborn if taken during pregnancy, especially in the second and third trimesters, and should not be used by women who are pregnant or may become pregnant. This medication is contraindicated for patients with certain conditions, such as those with hypersensitivity to this medication, severe liver impairment, cardiac issues, low blood pressure, shock, and women who are pregnant or breastfeeding. Patients with primary aldosteronism, aortic stenosis, liver diseases, gastrointestinal disorders, renal artery hypertension, renal insufficiency, elderly patients, etc., should use this medication with caution and have their blood pressure and kidney function monitored regularly. Common side effects such as dizziness and peripheral edema may occur while taking this medication, and serious side effects may occur rarely, so immediate consultation with a healthcare provider is needed if abnormal symptoms arise. If pregnancy is confirmed, this medication should be discontinued as soon as possible and replaced with a safer treatment option, and it is also advisable not to take this medication while breastfeeding. Since there is a risk of significantly dropping blood pressure or causing kidney function issues, caution is required, especially for patients taking diuretics or those with weak renal function. This medication may interact with other drugs, so inform your healthcare provider of any other medications you are taking, and avoid taking it with grapefruit juice. Drowsiness or dizziness may occur when driving or operating machinery, so caution is necessary. In case of overdose, symptoms such as hypotension, dizziness, cardiac issues may occur, and immediate emergency treatment is necessary. Store this medication out of reach of children, and it is recommended to open the packaging just before taking the medication.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 103 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbances
  • sensory loss
  • taste disturbances
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual disturbances
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • gastrointestinal bleeding
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormality
  • liver impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal impairment
  • acute renal failure
  • urinary disorders
  • increased urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that does not allow light in. Additionally, it is important to maintain a temperature between 1 to 30 degrees Celsius when storing the medication. This will help to maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

Biconvex oval bicolor tablet, white and light blue

Package unit

PTP - 30 tablets/PTP[(10 tablets/PTP x 3)], bottle packaging - 30 tablets/bottle, bottle packaging - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.